RxDoctor Payments Data

Christopher Smith, DO

Plastic and Reconstructive Surgery · New Orleans, LANPI 1194133504

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,274 of the $5,439 with a category attached, or 78.6%. 21 manufacturers reported payments, led by Mentor Worldwide LLC at 31.1% of the total.

$5,439in general payments, 2019–2025

Across 72 payments — averaging $75.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$2K
  • Medical Device Business Services, Inc.$1K
  • Musculoskeletal Transplant Foundation Inc.$380
  • Integra Lifesciences Corporation$303
  • Acera Surgical, Inc.$233
  • Organogenesis Inc.$231
  • plus $1K from 15 others

What the payments were for

  • Travel & lodging$1,16521%
  • Food & beverage$4,27479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,439 in reported general payments places this provider in the 75th percentile of 45 plastic and reconstructive surgery providers in Louisiana.

See all plastic and reconstructive surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$42,110
Medicare patients
31
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →